Recon: Biden admin eyes COVID booster shots at six months; AstraZeneca reports positive Phase 3 for Wilson disease drug
ReconMichael Mezher
Biologics/ biosimilars/ vaccinesBiotechnologyDiagnostics/IVDsGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy